Soft Interaction in Liposome Nanocarriers for Therapeutic Drug Delivery
Мягкие взаимодействия в липосомальных нанопереносчиках для доставки терапевтических лекарственных препаратов
2016-06-25
SCID: 54.1/q9ry4dv2
Discuss with AI
biological barrierscontrolled drug deliveryliposome nanocarrierssoft interactionstherapeutic drug delivery
Figures from the paper
Abstract (AI)
The development of smart nanocarriers for the delivery of therapeutic drugs has experienced considerable expansion in recent decades, with the development of new medicines devoted to cancer treatment. In this respect a wide range of strategies can be developed by employing liposome nanocarriers with desired physico-chemical properties that, by exploiting a combination of a number of suitable soft interactions, can facilitate the transit through the biological barriers from the point of administration up to the site of drug action. As a result, the materials engineer has generated through the bottom up approach a variety of supramolecular nanocarriers for the encapsulation and controlled delivery of therapeutics which have revealed beneficial developments for stabilizing drug compounds, overcoming impediments to cellular and tissue uptake, and improving biodistribution of therapeutic compounds to target sites. Herein we present recent advances in liposome drug delivery by analyzing the main structural features of liposome nanocarriers which strongly influence their interaction in solution. More specifically, we will focus on the analysis of the relevant soft interactions involved in drug delivery processes which are responsible of main behaviour of soft nanocarriers in complex physiological fluids. Investigation of the interaction between liposomes at the molecular level can be considered an important platform for the modeling of the molecular recognition processes occurring between cells. Some relevant strategies to overcome the biological barriers during the drug delivery of the nanocarriers are presented which outline the main structure-properties relationships as well as their advantages (and drawbacks) in therapeutic and biomedical applications.
Key Findings
1
Liposome nanocarriers can be engineered with tailored physicochemical properties to exploit multiple soft interactions during transport through biological barriers.
2
Liposome–liposome and liposome–environment interactions in physiological fluids strongly influence nanocarrier behavior, biodistribution, and delivery to target sites.
3
Molecular-level analysis of liposome interactions provides a platform for modeling recognition processes between nanocarriers and cells.
4
Strategies for overcoming biological barriers reveal structure–property relationships, therapeutic advantages, and drawbacks of liposome-based delivery systems.
5
Supramolecular liposome systems enable therapeutic encapsulation and controlled release while stabilizing drugs and improving cellular and tissue uptake.
Research Object
liposome nanocarriers for therapeutic drug delivery
Research Subject
the soft molecular interactions, structure–property relationships, and behavior of liposome nanocarriers in physiological fluids that govern biological-barrier transit, cellular and tissue uptake, biodistribution, and controlled drug delivery
Publication Details
Publication Date
2016-06-25
Journal
Publisher
ISSN
Cited by
177
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest